Myocardial salvage through coronary collateral growth by granulocyte colony-stimulating factor in chronic coronary artery disease: A controlled randomized trial

Circulation

Volumn 120, Issue 14, 2009, Pages 1355-1363

  Meier, Pascal ^a   Gloekler, Steffen ^a   De Marchi, Stefano F ^a   Indermuehle, Andreas ^a   Rutz, Tobias ^a   Traupe, Tobias ^a   Steck, Hélène ^a   Vogel, Rolf ^a   Seiler, Christian ^a  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Arteries; Collateral circulation; Coronary circulation; Granulocyte colony stimulating factor

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; PLACEBO;

ADULT; ARTICLE; BALLOON OCCLUSION; BONE PAIN; CENTRAL VENOUS PRESSURE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIARRHEA; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAM; FATIGUE; FEMALE; FOLLOW UP; HEADACHE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE; HEART MUSCLE PERFUSION; HEMODYNAMICS; HUMAN; HYPEREMIA; MAJOR CLINICAL STUDY; MALAISE; MALE; MYALGIA; PRIORITY JOURNAL; QT INTERVAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL;

AGED; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR DISEASES; CHEST PAIN; CHRONIC DISEASE; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEART CATHETERIZATION; HUMANS; HYPEREMIA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PLACEBOS; RISK FACTORS;

EID: 70349754505     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.866269     Document Type: Article

References (31)

1. Sobel BE, Bresnahan GF, Shell WE, Yoder RD. Estimation of infarct size in man and its relation to prognosis. Circulation. 1972;46:640-647.
2. Birnbaum Y, Kloner R. Percutaneous transluminal coronary angioplasty as a model of ischemic preconditioning and preconditioning-mimetic drugs. J Am Coll Cardiol. 1999;33:1036-1039.
3. Schaper W, Frenzel H, Hort W. Experimental coronary artery occlusion: measurement of infarct size. Basic Res Cardiol. 1979;74:46-53.
4. Meier P, Gloekler S, Zbinden R, Beckh S, de Marchi S, Zbinden S, Wustmann K, Billinger M, Vogel R, Cook S, Wenaweser P, Togni M, Windecker S, Meier B, CS. Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements. Circulation. 2007;116: 975-983.
5. Deindl E, Zaruba M, Brunner S, Huber B, Mehl U, Assmann G, Hoefer I, Mueller-Hoecker J, Franz W. G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis. FASEB J. 2006;20:956-958.
6. Friedman PL, Shook TL, Kirshenbaum JM, Selwyn AP, Ganz P. Value of the intracoronary electrocardiogram to monitor myocardial ischemia during percutaneous transluminal coronary angioplasty. Circulation. 1986;74:330-339.
7. de Marchi S, Meier P, Oswald P, Seiler C. Variable ECG signs of ischemia during controlled occlusion of the left and right coronary artery in humans. Am J Physiol. 2006;291:H351-H356.
8. Pijls NHJ, van Son JAM, Kirkeeide RL, De Bruyne B, Gould KL. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous coronary angioplasty. Circulation. 1993;86:1354-1367.
9. Seiler C, Fleisch M, Garachemani A, Meier B. Coronary collateral quan-titation in patients with coronary artery disease using intravascular flow velocity or pressure measurements. J Am Coll Cardiol. 1998;32: 1272-1279.
10. Vogel R, Zbinden R, Indermuhle A, Windecker S, Meier B, Seiler C. Collateral-flow measurements in humans by myocardial contrast echo-cardiography: validation of coronary pressure-derived collateral-flow assessment. Eur Heart J. 2006;27:157-165.
11. Matsuo H, Watanabe S, Kadosaki T, Yamaki T, Tanaka S, Miyata S, Segawa T, Matsuno Y, Tomita M, Fujiwara H. Validation of collateral fractional flow reserve by myocardial perfusion imaging. Circulation. 2002;105:1060-1065.
12. Vogel R, Indermuhle A, Reinhardt J, Meier P, Siegrist PT, Namdar M, Kaufmann PA, Seiler C. The quantification of absolute myocardial per-fusion in humans by contrast echocardiography: algorithm and validation. J Am Coll Cardiol. 2005;45:754-762.
13. Reimer KA, Jennings RB. The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest. 1979;40:633-644.
14. Murry C, Soonpaa M, Reinecke H, Nakajima H, Nakajima H, Rubart M, Pasumarthi K, Virag J, Bartelmez S, Poppa V, Bradford G, Dowell J, Williams D, Field L. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature. 2004;428:664-668.
15. Reffelmann T, Dow J, Dai W, Hale S, Simkhovich B, Kloner R. Transplantation of neonatal cardiomyocytes after permanent coronary artery occlusion increases regional blood flow of infarcted myocardium. J Mol Cell Cardiol. 2003;35:607-613.
16. Ziegelhoeffer T, Fernandez B, Kostin S, Heil M, Voswinckel R, Helisch A, Schaper W. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res. 2004;94:230-238.
17. Abdel-Latif A, Bolli R, Tleyjeh I, Montori V, Perin E, Hornung C, Zuba-Surma E, Al-Mallah M, Dawn B. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med. 2007;167:989-997.
18. Kastrup J, Ripa R, Wang Y, Jørgensen E. Myocardial regeneration induced by granulocyte-colony-stimulating factor mobilization of stem cells in patients with acute or chronic ischaemic heart disease: a non-invasive alternative for clinical stem cell therapy? Eur Heart J. 2006;27: 2748-2754.
19. Zohlnhöfer D, Dibra A, Koppara T, de Waha A, Ripa R, Kastrup J, Valgimigli M, Schömig A, Kastrati A. Stem cell mobilization by granu-locyte colony-stimulating factor for myocardial recovery after acute myo-cardial infarction: a meta-analysis. J Am Coll Cardiol. 2008;51: 1429-1437.
20. Seiler C, Pohl T, Wustmann K, Hutter D, Nicolet P, Windecker S, Eberli F, Meier B. Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Circulation. 2001; 104:2012-2017.
21. Zbinden S, Zbinden R, Meier P, Windecker S, Seiler C. Safety and efficacy of subcutaneous-only granulocyte-macrophage colony-stimulating factor for collateral growth promotion in patients with coronary artery disease. J Am Coll Cardiol. 2005;46:1636-1642.
22. Vogel R, Indermühle A, Meier P, Seiler C. Quantitative stress echocar-diography in coronary artery disease using contrast-based myocardial blood flow measurements: prospective comparison with coronary angiography. Heart. 2009;95:377-384.
23. van Royen N, Hoefer I, Buschmann I, Kostin S, Voskuil M, Bode C, Schaper W, Piek J. Effects of local MCP-1 protein therapy on the development of the collateral circulation and atherosclerosis in Watanabe hyperlipidemic rabbits. Cardiovasc Res. 2003;57:178-185.
24. Buschmann I, Hoefer I, van Royen N, Katzer E, Braun-Dulleaus R, Heil M, Kostin S, Bode C, Schaper W. GM-CSF: a strong arteriogenic factor acting by amplification of monocyte function. Atherosclerosis. 2001;159: 343-356.
25. van Royen N, Hoefer I, Buschmann I, Heil M, Kostin S, Deindl E, Vogel S, Korff T, Augustin H, Bode C, Piek J, Schaper W. Exogenous application of transforming growth factor beta 1 stimulates arteriogenesis in the peripheral circulation. FASEB J. 2002;16:432-434.
26. Deindl E, Hoefer I, Fernandez B, Barancik M, Heil M, Strniskova M, Schaper W. Involvement of the fibroblast growth factor system in adaptive and chemokine-induced arteriogenesis. Circ Res. 2003;92: 561-568.
27. Grundmann S, Hoefer I, Ulusans S, van Royen N, Schirmer S, Ozaki C, Bode C, Piek J, Buschmann I. Anti-tumor necrosis factor-{alpha} therapies attenuate adaptive arteriogenesis in the rabbit. Am J Physiol. 2005;289:H1497-H1505.
28. Cai W, Koltai S, Kocsis E, Scholz D, Kostin S, Luo X, Schaper W, Schaper J. Remodeling of the adventitia during coronary arteriogenesis. Am J Physiol. 2003;284:H31-H40.
29. van Royen N, Schirmer S, Atasever B, Behrens C, Ubbink D, Buschmann E, Voskuil M, Bot P, Hoefer I, Schlingemann R, Biemond B, Tijssen J, Bode C, Schaper W, Oskam J, Legemate D, Piek J, Buschmann I. START Trial: a pilot study on STimulation of ARTeriogenesis using subcutaneous application of granulocyte-macrophage colony-stimulating factor as a new treatment for peripheral vascular disease. Circulation. 2005;112: 1040-1046.
30. Abdel-Latif A, Bolli R, Zuba-Surma E, Tleyjeh I, Hornung C, Dawn B. Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. Am Heart J. 2008;156:216-226.
31. Maroko PR, Kjekshus JK, Sobel BE, Watanabe T, Covell JW, Ross JJ, Braunwald E. Factors influencing infarct size following experimental coronary artery occlusions. Circulation. 1971;43:67-82